Answer
Inotuzumab ozogamicin (BESPONSA) has a moderate influence on driving and using machines and may cause fatigue during treatment, so caution is recommended when driving or operating machinery.
Sources for this answer
- BESPONSA 1 mg powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 11Document updated
Sources checked